Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2005-12-09
2009-08-04
Mertz, Prema (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S143100, C530S387300, C530S388220
Reexamination Certificate
active
07569224
ABSTRACT:
Nucleic acids encoding mammalian cytokine receptor, e.g., for cytokine IL-B50, purified proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are described.
REFERENCES:
patent: 5194375 (1993-03-01), Park et al.
patent: 6861227 (2005-03-01), Ruben et al.
patent: 6890734 (2005-05-01), Reche-Gallardo et al.
patent: 6955895 (2005-10-01), Pandey et al.
patent: 7071308 (2006-07-01), Reche-Gallardo et al.
patent: 2002/0068323 (2002-06-01), Saris et al.
patent: WO 99 47538 (1999-09-01), None
patent: WO 00 17362 (2000-03-01), None
patent: WO 02/00724 (2002-01-01), None
Akashi, Koich, et al.,Curr Opin Immunol, 12(2):144-150, Apr. 2000. “Lymphoid precursors”.
Aspinall and Andrew,Vaccine, 18(16):1629-1637, Feb. 25, 2000. “Thymic atrophy in the mouse is a soluble problem of the thymic environment”.
Beverley and Grubeck-Loebenstein,Vaccine, 18(16):1721-1724, Feb. 25, 2000. “Is immune senescence reversible?”.
Bolin, Laurel M., et al.,J Neurosci, 17(14):5493-5502, Jul. 15, 1997. “HNMP-1: a novel hematopoietic and neural membrane protein differentially regulated in neural developmemt and injury”.
Fehniger, Todd A., et al.,J Immunol, 162(8):4511-4520, Apr. 15, 1999. “Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response”.
Kadowaki, Norimitsu, et al.,J Exp Med, 192(2):219-226, Jul. 17, 2000. “Natural interferon alpha/beta-producing cells link innate and adaptive immunity”.
Katz, Bradley A.,Biomol Eng, 16(1-4):57-65, Dec. 31, 1999. “Streptavidin-binding and -dimerizing ligands discovered by phage display, topochemistry, and structure-based design”.
Kelleher and Rowland-Jones,Curr Opin Immunol, 12(4):370-374, Aug. 2000. “Functions of tetramer-stained HIV-specific CD4(+) and CD8(+) T cells”.
Kitamura, Toshio,Int J Hematol, 67(4):351-359, Jun. 1998. “New experimental approaches in retrovirus-mediated expression screening”.
Koppelman, Bruce, et al.,Immunity, 7(6):861-871, Dec. 1997. “Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling”.
Levin, S. D. et al.,FASEB Journal, vol. 13, No. 4, Part 1, Mar. 12, 1999, p. A322, XP008014578, Annual Meeting of the Professional Research Scientists for Experimental Biology 99, Washington DC, USA, Apr. 17-21, 1999, ISSN 0892-6638, the whole document. “Thymic stromal lymphopoeitin (TSLP): A cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism”.
Ogg and McMichael,Curr Opin Immunol, 10(4):393-396 Aug. 1998. “HLA-peptide tetrameric complexes”.
Pandey, A. et al.,Nature Immunology, United States Jul. 2000, vol. 1, No. 1, Jul. 2000, pp. 59-64, XP008014551, ISSN 1529-2908, abstract: figures 1,4,5,7. “Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin”.
Park, Linda S., et al.J Exp Med, 192(5):659-670, Sep. 4, 2000. “Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor”.
Puel and Leonard,Curr Opin Immunol, 12(4):468-73, Aug. 2000. “Mutations in the gene for the IL-7 receptor result in T(−)B(+)NK(+) severe combined immunodeficiency disease”.
Sims, John E., et al.,J Exp Med, 192(5):671-680, Sep. 4, 2000. “Molecular cloning and biological characterization of a novel murine lymphoid growth factor”.
Stoddart, Angela, et al.,Immunol Rev, 175:47-58, Jun. 2000. “The role of the preBCR, the interleukin-7 receptor, and homotypic interactions during B-cell development”.
Waldmann, T.A.,Ann Oncol, 11 Suppl 1:101-106, 2000. “T-cell receptors for cytokines: targets for immunotherapy of leukemia/lymphoma”.
Bazan J. Fernando
de Waal Malefyt Rene
Kastelein Robert A.
Liu Yong-Jun
Reche-Gallardo Pedro A.
Mertz Prema
Schering Corporation
LandOfFree
Mammalian cytokines; receptors; related reagents and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mammalian cytokines; receptors; related reagents and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian cytokines; receptors; related reagents and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4079696